NTT Research Formulates System to Optimize Drug Infusion for Acute Heart Failure

MEI Lab Advances Work on Cardiovascular Bio Digital Twin in Conference Paper and Tests Proof of Concept with Japan’s National Cerebral and Cardiovascular Center (NCVC) Sunnyvale, Calif. – September 21, 2022 – NTT Research, Inc., a division of NTT (TYO:9432), today announced that its Medical & Health Informatics (MEI) Lab has delivered a paper proposing a system design …

NTT Research Formulates System to Optimize Drug Infusion for Acute Heart Failure Read More »